|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Website of Health Promotion
Administration, Ministry of Health and Welfare, Taiwan, .
2019.https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/10227/File_11644.pdf
|
|
3
|
Tan DS, Miller RE and Kaye SB: New
perspectives on molecular targeted therapy in ovarian clear cell
carcinoma. Br J Cancer. 108:1553–1559. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaw TJ, Senterman MK, Dawson K, Crane CA
and Vanderhyden BC: Characterization of intraperitoneal,
orthotopic, and metastatic xenograft models of human ovarian
cancer. Mol Ther. 10:1032–1042. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL:
Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okamoto A: Management and new strategy of
ovarian clear cell carcinoma. Int J Clin Oncol. 25:4182020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang L, Wang Y, Rong Y, Xu L, Chu Y,
Zhang Y and Yao Y: MiR-1179 promotes cell invasion through
SLIT2/ROBO1 axis in esophageal squamous cell carcinoma. Int J Clin
Exp Pathol. 8:319–327. 2015.PubMed/NCBI
|
|
10
|
Tseng RC, Chang JM, Chen JH, Huang WR,
Tang YA, Kuo IY, Yan JJ, Lai WW and Wang YC: Deregulation of
SLIT2-mediated Cdc42 activity is associated with esophageal cancer
metastasis and poor prognosis. J Thorac Oncol. 10:189–198. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang Z, Liang G, Xiao Y, Qin T, Chen X,
Wu E, Ma Q and Wang Z: Targeting the SLIT/ROBO pathway in tumor
progression: Molecular mechanisms and therapeutic perspectives.
Ther Adv Med Oncol. 11:17588359198552382019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lucas B and Hardin J: Mind the
(sr)GAP-roles of Slit-Robo GAPs in neurons, brains and beyond. J
Cell Sci. 130:3965–3974. 2017.PubMed/NCBI
|
|
13
|
Blockus H and Chédotal A: Slit-Robo
signaling. Development. 143:3037–3044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu H, Zhu J, Yu J, Pu H and Dong R: SLIT2
is epigenetically silenced in ovarian cancers and suppresses growth
when activated. Asian Pac J Cancer Prev. 12:791–795.
2011.PubMed/NCBI
|
|
15
|
Dai CF, Jiang YZ, Li Y, Wang K, Liu PS,
Patankar MS and Zheng J: Expression and roles of Slit/Robo in human
ovarian cancer. Histochem Cell Biol. 135:475–485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong R, Yu J, Pu H, Zhang Z and Xu X:
Frequent SLIT2 promoter methylation in the serum of patients with
ovarian cancer. J Int Med Res. 40:681–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dickinson RE and Duncan WC: The SLIT-ROBO
pathway: A regulator of cell function with implications for the
reproductive system. Reproduction. 139:697–704. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sirohi VK, Popli P, Sankhwar P, Kaushal
JB, Gupta K, Manohar M and Dwivedi A: Curcumin exhibits anti-tumor
effect and attenuates cellular migration via Slit-2 mediated
down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma
cells. J Nutr Biochem. 44:60–70. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang PH, Hwang-Verslues WW, Chang YC,
Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY and Lee WH:
Activation of Robo1 signaling of breast cancer cells by Slit2 from
stromal fibroblast restrains tumorigenesis via blocking
PI3K/Akt/β-catenin pathway. J Cancer Res. 72:4652–4661. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marchini S, Mariani P, Chiorino G,
Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V,
Cinquini M, et al: Analysis of gene expression in early-stage
ovarian cancer. Clin Cancer Res. 14:7850–7860. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Makii C, Oda K, Sone K, Sone K, Hasegawa
K, Uehara Y, Nishijima A, Asada K, Koso T, Fukuda T, et al: MDM2 is
a potential therapeutic target and prognostic factor for ovarian
clear cell carcinomas with wild type TP53. Oncotarget.
7:75328–75338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaguchi K, Huang Z, Matsumura N, Mandai
M, Okamoto T, Baba T, Konishi I, Berchuck A and Murphy SK:
Epigenetic determinants of ovarian clear cell carcinoma biology.
Int J Cancer. 135:585–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang J, Shin SH, Yoon H, Huh J, Shin HW,
Chun YS and Park JW: FIH is an oxygen sensor in ovarian cancer for
G9a/GLP-Driven epigenetic regulation of metastasis-related genes.
Cancer Res. 78:1184–1199. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang JM, Tsai AC, Huang WR and Tseng RC:
The alteration of CTNNBIP1 in lung cancer. Int J Mol Sci.
20:56842019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LH, Wu CF, Rajasekaran N and Shin YK:
Loss of tumor suppressor gene function in human cancer: An
overview. Cell Physiol Biochem. 51:2647–2693. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dickinson RE, Myers M and Duncan WC: Novel
regulated expression of the SLIT/ROBO pathway in the ovary:
Possible role during luteolysis in women. Endocrinology.
149:5024–5034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dickinson RE, Fegan KS, Ren X, Hillier SG
and Duncan WC: Glucocorticoid regulation of SLIT/ROBO tumour
suppressor genes in the ovarian surface epithelium and ovarian
cancer cells. PLoS One. 6:e277922011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jeon MJ, Lim S, You MH, Park Y, Song DE,
Sim S, Kim TY, Shong YK, Kim WB and Kim WG: The role of Slit2 as a
tumor suppressor in thyroid cancer. Mol Cell Endocrinol. 483:87–96.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Göhrig A, Detjen KM, Hilfenhaus G, Körner
JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B
and Fischer C: Axon guidance factor SLIT2 inhibits neural invasion
and metastasis in pancreatic cancer. Cancer Res. 74:1529–1540.
2014. View Article : Google Scholar
|
|
34
|
Tseng RC, Lee SH, Hsu HS, Chen BH, Tsai
WC, Tzao C and Wang YC: SLIT2 attenuation during lung cancer
progression deregulates beta-catenin and E-cadherin and associates
with poor prognosis. Cancer Res. 70:543–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stella MC, Trusolino L and Comoglio PM:
The Slit/Robo system suppresses hepatocyte growth factor-dependent
invasion and morphogenesis. Mol Biol Cell. 20:642–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
